News

New Ozempic alternative only needs to be taken once a month and leads to ‘substantial weight loss’
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
Amgen experimental weight-loss drug needs lower dose to limit side effects
Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like ...
Devdiscourse3d
Amgen's MariTide: Promising Weight Loss with Milder Side Effects
Amgen's experimental obesity drug MariTide showed promising weight loss results with fewer side effects, according to a ...
The Independent3d
Trial finds weight loss drug taken monthly helps people lose 20% of body weight - The Independent
Weight loss medications such as Ozempic, Wegovy and Mounjaro have become popular and now there’s a new GLP-1 drug, MariTide, being tested that could be competitive in the market.
BioPharma Dive2d
New Amgen obesity drug data disappoint Wall Street
Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...
Fierce Biotech3d
Amgen rolls out ph. 3 dosing plan for lead obesity candidate after midstage trial sees high discontinuation, vomiting rates
While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, ...
Lilly, Novo, and Amgen set for key obesity trial readouts at upcoming ADA event
Novo Nordisk (NVO), and Amgen (NASDAQ:AMGN) are scheduled to present major clinical trial readouts at the American Diabetes ...